Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane.
Open Access
- 1 December 1994
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 180 (6), 2341-2346
- https://doi.org/10.1084/jem.180.6.2341
Abstract
Intraperitoneal injection of pristane (2,6,10,14 tetramethylpentadecane) is a standard technique for obtaining monoclonal antibody-enriched ascitic fluid. However, pristane also induces plasmacytomas and an erosive arthritis resembling rheumatoid arthritis in BALB/c mice, probably as a consequence of enhanced interleukin 6 production. We report here that the production of autoantibodies characteristic of systemic lupus erythematosus (SLE) is a further consequence of injecting pristane in BALB/c mice. Anti-Su antibodies appeared as early as 1-2 mo after a single injection of 0.5 ml pristane, followed by anti-U1RNP and anti-Sm antibodies after 2-4 mo. Within 6 mo of pristane injection, 9 of 11 BALB/c mice had developed anti-Su, anti-U1RNP, anti-U2RNP, anti-Sm, and possibly anti-U5RNP antibodies. Autoantibodies were not produced by 20 BALB/c mice of the same age and sex that were not injected with pristane. Thus, autoantibodies characteristic of lupus were induced in mice that are not usually considered to be genetically susceptible to the disease. The induction of autoantibodies associated with SLE by pristane may be relevant to understanding the role of abnormal cytokine production in autoantibody production and the pathogenesis of autoimmune disease. Furthermore, the induction of high titer autoantibodies by pristane dictates caution in the use of ascitic fluid as a source of monoclonal antibodies, since the polyclonal antibodies induced by pristane may copurify with the monoclonal antibody secreted by an injected hybridoma.Keywords
This publication has 28 references indexed in Scilit:
- Characterization of the Su Antigen, a Macromolecular Complex of 100/102 and 200-kDa Proteins Recognized by Autoantibodies in Systemic Rheumatic DiseasesClinical Immunology and Immunopathology, 1994
- Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor.The Journal of Experimental Medicine, 1990
- Pristane‐induced arthritis. the immunologic and genetic features of an experimental murine model of autoimmune diseaseArthritis & Rheumatism, 1989
- 20S small nuclear ribonucleoprotein U5 shows a surprisingly complex protein composition.Proceedings of the National Academy of Sciences of the United States of America, 1989
- A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30gag antigenCell, 1987
- IN vitro production of autoantibodies to u1 ribonucleoproteins by peripheral blood mononuclear cells from patients with connective tissue diseasesArthritis & Rheumatism, 1986
- [34] The effect of pristane on ascites tumor formation and monoclonal antibody productionMethods in Enzymology, 1986
- Small nuclear ribonucleoprotein particle assembly in vivo: Demonstration of a 6S RNA-free core precursor and posttranslational modificationCell, 1985
- Presence of anti-Sm reactivity in autoimmune mouse strainsThe Journal of Experimental Medicine, 1978
- Induction of Plasma Cell Tumours in BALB/c Mice with 2,6,10,14-Tetramethylpentadecane (Pristane)Nature, 1969